Lunai Bioworks LNAI
NASDAQ LNAI
$0.16 -0.08 (-33.33%)
At close: Oct 29, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Gains (Losses) on Sale of Assets & Investments (2025)

Updated

Analysis

Lunai Bioworks (LNAI) Gains (Losses) on Sale of Assets & Investments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,239.46 Bn 1,213.08 Bn 20.46 Bn -
2 Johnson & Johnson 667.12 Bn 586.98 Bn 17.30 Bn -
3 AbbVie 514.05 Bn 482.06 Bn 13.12 Bn -
4 Merck 362.55 Bn 325.49 Bn 13.19 Bn -
5 Novartis Ag 313.81 Bn 287.05 Bn - -
6 Astrazeneca 291.69 Bn 265.59 Bn 13.26 Bn -
7 Amgen 247.31 Bn 198.96 Bn 7.58 Bn -
8 Gilead Sciences 208.37 Bn 183.48 Bn 6.73 Bn -
9 Pfizer 165.98 Bn 113.34 Bn 12.56 Bn -
10 Lunai Bioworks 537,744.47 537,744.47 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 210,281.00
API Access

Lunai Bioworks Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LNAI&period=max&api_key=YOUR_API_KEY